Please login to the form below

Not currently logged in
Email:
Password:

Latuda

This page shows the latest Latuda news and features for those working in and with pharma, biotech and healthcare.

EU approval for Takeda’s schizophrenia drug

EU approval for Takeda’s schizophrenia drug

Takeda and development partner Dainippon Sumitomo Pharma have won European approval for their schizophrenia treatment Latuda (lurasidone). ... Smith previously described Latuda as a potential blockbuster in an interview with PMLiVE.

Latest news

  • GSK's diabetes drug among CHMP recommendations GSK's diabetes drug among CHMP recommendations

    s antipsychotic Latuda and Linepharma France's Hemoprostol for haemorrhage in women. ... 2013. Takeda's antipsychotic and Linepharma's Hemoprostol. Elsewhere in the CHMP opinions, Takeda received a recommendation for the use of Latuda (lurasidone) in the

  • Coronary conundrums

    US. Lurasidone. Latuda (Sunovion Pharmaceuticals). Schizophrenia. US an Puerto Rico. Paracetamol.

More from news
Approximately 2 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OPEN Health

OPEN Health is a family of expert practices, working in partnership to drive positive change in healthcare communications & market...

Latest intelligence

My MS journey: one patient's search for innovation
David Lazarus charts his journey from initial MS diagnosis in 1990 to his experience participating in innovative clinical trials, along with his advice for other patients....
Biotech profile: Tom Evans, CEO, Vaccitech.
Can UK company be first to develop a universal flu vaccine?...
The social dilemma: is it time for pharma to join the party?
Chris Ross explores why social media still isn’t trending for pharma, and how it can join in the fun...

Infographics